(Correcting the description of the company in the third paragraph)
China Resources Medical (HKG:1515) recorded a rise in attributable profit for the year 2024 to 565.9 million yuan from 257.7 million yuan a year prior, a Tuesday filing with the Hong Kong bourse said.
Earnings per share were 0.45 yuan in the year, up from 0.20 yuan in the last fiscal year.
The hospital business firm's revenue fell to 9.85 billion yuan in the period from 10.1 billion yuan a year prior.
The company has proposed a final dividend of 0.082 yuan per share for the year, payable on or before July 21 to shareholders of record on June 12.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.